Sandbox Reserved 1703
From Proteopedia
(Difference between revisions)
| Line 13: | Line 13: | ||
===Overall Structure=== | ===Overall Structure=== | ||
| - | Cryo-EM studies of mGlu2 have yielded adequate structures that have acted as maps to aid in producing a better structural understanding of the inactive and active states of mGlu2 | + | Cryo-EM studies of mGlu2 have yielded adequate structures that have acted as maps to aid in producing a better structural understanding of the inactive and active states of mGlu2<ref name="Lin" />. The overall structure of the mGlu2 is composed of 3 main parts: a ligand binding Venus FlyTrap Domain(VFT), followed by a Cysteine Rich Domain linker to the Transmembrane Domain that contains 7 alpha helices (7TM) on both the <scene name='90/905587/Alphaandbetachain/2'>alpha and beta chains</scene> that aid in the binding of the G-Protein. Class C CPCRs such as mGlu2, are activated by their ability to form dimers. MGlu2 is a homodimer which is imperative to the receptor’s ability to relay signals induced by glutamate from the extracellular domain(ECD) to its transmembrane domain(TMD). The homodimer of mGlu2 contains an alpha chain and a beta chain. Occupation of both ECDs with the agonist, glutamate, is necessary for a fully active mGlu2. However, only one chain in the dimer is responsible for activation of the G-protein, this suggests an asymmetrical signal transduction mechanism for mGlu2. |
===Inactive State=== | ===Inactive State=== | ||
Revision as of 23:33, 27 March 2022
Metabotropic Glutamate Receptor 2
| |||||||||||
References
- ↑ 1.0 1.1 1.2 Lin, Shuling, et al. “Structures of GI-Bound Metabotropic Glutamate Receptors mglu2 and mglu4.” Nature News, Nature Publishing Group, 16 June 2021,https://www.nature.com/articles/s41586-021-03495-2>
- ↑ Seven, Alpay B., et al. “G-Protein Activation by a Metabotropic Glutamate Receptor.” Nature News, Nature Publishing Group, 30 June 2021, https://www.nature.com/articles/s1586-021-03680-3
- ↑ Zhang, Zhu, et al. “Roles of Glutamate Receptors in Parkinson's Disease.” MDPI, Multidisciplinary Digital Publishing Institute, 6 Sept. 2019, https://dx.doi.org/10.3390%2Fijms20184391.>
- ↑ Yang, Hong-Ju, et al. “Deletion of Type 2 Metabotropic Glutamate Receptor Decreases Sensitivity to Cocaine Reward in Rats.” Cell Reports, U.S. National Library of Medicine, 11 July 2017, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555082/.>
Student Contributors
Frannie Brewer and Ashley Wilkinson
